liver cancer

Delcath: A Cancer Treatment Biotech With Good Short And Long-Term Potential

Delcath: A Cancer Treatment Biotech With Good Short And Long-Term Potential

Seeking Alpha

Is Delcath The Post-Celsion Play On Liver Cancer?

Is Delcath The Post-Celsion Play On Liver Cancer?

Seeking Alpha

Celsion: Run-Up Trade Into Thermodox Results

Celsion: Run-Up Trade Into Thermodox Results

TheStreet.com

Sirtex Deal Elevated With Liver Cancer Therapy: Real M&A

Sirtex Deal Elevated With Liver Cancer Therapy: Real M&A

Bloomberg

4SC in Talks With 3 Potential Partners for Cancer Drug

4SC in Talks With 3 Potential Partners for Cancer Drug

Bloomberg

Bayer says Nexavar-Tarceva trial unsuccessful

Bayer says Nexavar-Tarceva trial unsuccessful

Reuters

Cramer: What Celgene’s Europe News Means

Cramer: What Celgene’s Europe News Means

CNBC

New Drug Could Be Game Changer For Sanofi

New Drug Could Be Game Changer For Sanofi

Seeking Alpha

India licenses generic copy of patented Bayer drug

India licenses generic copy of patented Bayer drug

Yahoo/AP

Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial

Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial

Bloomberg